CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) Trial The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y Primary Prevention of Heart Failure in Women Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart Failure Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study Nuclear Imaging of the Cardiac Sympathetic Nervous System: A Disease-Specific Interpretation in Heart Failure Heart Failure Outcomes With Volume-Guided Management Clinical applications of machine learning in the diagnosis, classification, and prediction of heart failure SPECT and PET in ischemic heart failure

Original Research2019 May;21(5):665-675.

JOURNAL:Eur J Heart Fail. Article Link

A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)

McMurray JJV, DeMets DL, DAPA-HF Committees and Investigators. Keywords: protocol; heart failure; sodium-glucose co-transporter 2 inhibitor; type 2 diabetes mellitus

FULL TEXT PDF